Resveratrol ameliorates fibrosis and inflammation in a mouse model of nonalcoholic steatohepatitis

Takaomi Kessoku(International University of Health and Welfare), Atsushi Nakajima(Yokohama City University)

Scientific Reports

February 25, 2016

10.1038/srep22251

Cited by 83

Related Papers

Vibration-Controlled Transient Elastography Scores to Predict Liver-Related Events in Steatotic Liver Disease

|JAMA|2024|200

Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition

|Gut|2008|183

The Selective SGLT2 Inhibitor Ipragliflozin Has a Therapeutic Effect on Nonalcoholic Steatohepatitis in Mice

|PLoS ONE|2016|169

Pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha modulator, improves the pathogenesis in a rodent model of nonalcoholic steatohepatitis

|Scientific Reports|2017|128

Long-term liver-related outcomes and liver stiffness progression of statin usage in steatotic liver disease

|Gut|2024|80